References
- Vitali C, Bombardieri S, Mountpoulos HM, Balestrieri G, Bencivelli W, Bernstein RM, et al. Preliminary criteria for the classification of SjOgren's syndrome. Results of a prospective concerted action sup-ported by the European Community. Arthritis Rheum 1993;36:340–7.
- Rose AL, Walton JN. Polymyositis. A survey of 89 cases with particular reference to treatment and prognosis. Brain 1966;89: 747–68.
- Martinez-Lavin M, Vaughan JH, Tan EM. Autoantibodies and the spectrum of SjOgren's syndrome. Ann Intern Med 1979;91:185–90.
- Vrethen M, Lindvall VM, Holmgren H, Henriksson K-G, Lindstrom F, Ernerudh J, et al. Neurohistological, immunological and muscle biopsy results. Acta Neurol Scand 1990;82:126–31.
- Kraus A, Cifuentes M, Villa AR, Jakez J, Reyes E, Alarcon-Segovia A. Myositis in primary SjOgren's syndrome. Report on three cases. J Ftheumatol 1994;21:649–53.
- Alexander EL, Jositek L, Provost TT, Alexander GE. Myositis/ vasculitis in primary SjOgren's syndrome (SS) [abstract]. Arthritis Rheum 1982;25:S15.
- Leroy JP, Drosos AA, Yiannopoulous DI, Youinou P, Mountpoulos HM. Intravenous pulse cyclophosphamide therapy in myositis and SjOgren's syndrome. Arthritis Rheum 1990;33:1579–81.
- Bohan A, Johan A, Peter JB. Polymyositis and dermatomyositis. Parts 1 and 2. N Engl J Med 1975;292: 343–7,403–7.
- Gran JT, Myklbust G. The concomitant occurrence of SjOgren's syndrome and polymyositis. Scand J Ftheumatol 1992;21:150–4.